BrightSpring Health Services reported total current assets of $2.77 billion as of September 30, 2026, a slight decrease from $2.89 billion at year-end 2025, primarily due to the disposition of assets held for sale. The company maintained a significant cash position of $717.8 million and reported 198,984,612 shares of common stock outstanding as of October 27, 2026.
BrightSpring Health Services reported Q3 2026 net revenue of $4.21 billion, a 26.4% increase year-over-year, and net income from continuing operations of $101 million. Following the strong performance in its Pharmacy and Provider segments, the company increased its full-year 2026 revenue and Adjusted EBITDA guidance.
Term
Q3 2026
“Our third quarter results again reflect the commitment of our team to patient care and operational execution across our Pharmacy and Provider businesses. We have a differentiated company, our value proposition for healthcare stakeholders is clear, and our confidence in the future remains high, supported by a broad set of process and growth drivers across a uniquely scaled and high-quality platform.”
Jon Rousseau, Chairman, President, and Chief Executive Officer
BrightSpring Health Services President, PharMerica Scott A. Greenwell Sells $874K of Stock
Scott A. Greenwell, President, PharMerica, sold 15,099 shares of BrightSpring Health Services, Inc. at $57.91 a share, worth $874K in total on Sep 14, 2026. Shares held after the trade: 31,246 (-32.6%).